search for books and compare prices
cancer chemotherapy matches 354 work(s)
at beginning | displaying 1 to 25 | next 25 >
Jump to start at |
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9780817637750 Cover for 9781461598541 Cover for 9780841230408 Cover for 9781573311847 Cover for 9783540605997 Cover for 9780841237452 Cover for 9780824771898 Cover for 9780896034617 Cover for 9781588292285 Cover for 9781461581543 Cover for 9780792329282 Cover for 9780792328360 Cover for 9781461361299 Cover for 9780471036579 Cover for 9783540612018 Cover for 9783642802423 Cover for 9780896035966 Cover for 9781475745214 Cover for 9780471080800 Cover for 9780897662321 Cover for 9781881025283 Cover for 9780849355202 Cover for 9780849355219 Cover for 9780849346200
cover image for 9781461598541
Product Description: Nullius in verba. . . Truth will be tested not by words. Horace (Epistles) Few read introductions except for book reviewers, who want to take a shortcut and avoid reading the book itself. However, tradition requires that the preface make public why the book was written at all (this is not supposed to include powerful reasons such as augmenting the ego of the editor and authors)...read more
By John A. Kellen (editor)

Hardcover:

9780817637750 | Birkhauser, March 1, 1995, cover price $99.00 | About this edition: Nullius in verba.

Paperback:

9781461598541 | Birkhauser, February 12, 2012, cover price $119.00 | About this edition: Nullius in verba.

cover image for 9780841230408
Product Description: Covers the synthesis of promising new analogues. Studies structure-activity relationships of anthracycline antibiotics. Investigates new approaches to improving properties for anthracyclines by using different drug-delivery and tumor-targeting systems...read more

Hardcover:

9780841230408 | Amer Chemical Society, May 5, 1995, cover price $24.95 | About this edition: Covers the synthesis of promising new analogues.

cover image for 9781573311847
By Hiroshi Maruta (editor)

Hardcover:

9781573311847 | New York Academy of Sciences, March 1, 2000, cover price $140.00

cover image for 9783540605997
Product Description: The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons :o/hy such an initiative was considered necessary...read more
By L. Denis (editor)

Hardcover:

9783540605997 | Springer Verlag, February 1, 1996, cover price $99.00 | About this edition: The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer.

cover image for 9780841237452
Product Description: Describes cutting edge approaches in the development of anticancer agents for chemotherapy. These new and interdisciplinary approaches are aimed at the development of tumor specific anticancer agents while increasing the potency against drug-resistant tumors...read more

Hardcover:

9780841237452 | Amer Chemical Society, December 13, 2001, cover price $315.00 | About this edition: Describes cutting edge approaches in the development of anticancer agents for chemotherapy.

cover image for 9780824771898
Product Description: Book by Ottenbrite, Raphael M., Butler, George

Hardcover:

9780824771898 | Marcel Dekker Inc, September 1, 1984, cover price $155.00 | About this edition: Book by Ottenbrite, Raphael M.

cover image for 9781461581543
Product Description: Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests...read more
By Beverly A. Teicher (editor)

Hardcover:

9781588292285 | 2 har/cdr edition (Humana Pr Inc, February 1, 2004), cover price $289.00 | About this edition: This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent.
9780896034617 | Humana Pr Inc, April 1, 1997, cover price $99.00 | About this edition: Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval.

Paperback:

9781461581543 | 1 edition (Humana Pr Inc, June 25, 2013), cover price $99.00 | About this edition: Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval.

cover image for 9780792329282
Product Description: With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer...read more

Hardcover:

9780792329282 | Kluwer Academic Pub, June 1, 1994, cover price $449.00 | About this edition: With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer.

By S. Eckhardt (editor) and K. Lapis

Hardcover:

9783805544252 | S Karger Pub, January 1, 1987, cover price $66.75

cover image for 9781461361299
Product Description: Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year...read more
By Lori J. Goldstein (editor) and Robert F. Ozols (editor)

Hardcover:

9780792328360 | Kluwer Academic Pub, December 1, 1994, cover price $479.00 | About this edition: Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease.

Paperback:

9781461361299 | Reprint edition (Springer Verlag, October 11, 2012), cover price $479.00 | About this edition: Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease.

cover image for 9780471036579
Product Description: Affords researchers ready access to a vast body of information on identifying and isolating natural anticancer agents… The authors open this valuable text/reference with an in-depth exploration of the vast potential of plant, animal, microorganism constituents as sources for new and effective anticancer, antiviral drugs...read more (view table of contents, read Amazon.com's description)

Hardcover:

9780471036579 | Wiley-Interscience, March 1, 1994, cover price $170.00 | About this edition: Affords researchers ready access to a vast body of information on identifying and isolating natural anticancer agents… The authors open this valuable text/reference with an in-depth exploration of the vast potential of plant, animal, microorganism constituents as sources for new and effective anticancer, antiviral drugs.

cover image for 9783642802423
Product Description: Much progress has been made in the treatment of emesis caused by antineoplastic therapy, and particularly chemotherapy. However, some aspects remain controversial and the subject of continued research. This completely updated comprehensive manual on antiemetics covers a wide range of clinically relevant topics, providing the reader with a good source of easy consultation, and giving an overall picture of the state of the art and some clues for future development...read more
By M. Tonato (editor)

Hardcover:

9783540612018 | Springer Verlag, June 1, 1996, cover price $99.00 | About this edition: Much progress has been made in the treatment of emesis caused by antineoplastic therapy, and particularly chemotherapy.

Paperback:

9783642802423 | Reprint edition (Springer Verlag, December 14, 2011), cover price $149.00 | About this edition: Much progress has been made in the treatment of emesis caused by antineoplastic therapy, and particularly chemotherapy.

cover image for 9781475745214
Antifolates are an important class of anticancer drugs originally developed as anti leu kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase. Furthermore, folate supplementation in the form of leucovorin, modulates 5-fluororuacil activity. 5-Fluorouracil is widely used in the treatment of colorectal and gastric cancer and in combination for other solid tumors such as breast and head and neck cancers. Ongoing clinical trials with the newer antifolates suggest that the range of solid tumors where these agents will be of use may broaden further. Half a century ago, interesting scientific and clinical discoveries suggested that folie acid was a vitamin involved in vital cellular metabolic processes. The folate analogs, aminopterin and methotrexate, were synthesized by the American Cyanamid Company in an attempt to interfere with these processes and were shown to have anticancer activity by Farber and his colleagues. Hence, the principle of antimetabolite therapy for the treatment of cancer was established. Biomedical research over the following years led to a deeper understanding of the complex biochemical pharmacology of folates and antifolates. Selective antimicrobial agents were discovered, but more tumor-selective anticancer agents did not immediately emerge.
By Ann L. Jackman (editor)

Hardcover:

9780896035966 | Humana Pr Inc, March 1, 1999, cover price $299.00 | About this edition: Antifolates are an important class of anticancer drugs originally developed as anti leu kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar comas.

Paperback:

9781475745214 | Reprint edition (Humana Pr Inc, March 24, 2013), cover price $229.00

cover image for 9780471080800
Product Description: A multidisciplinary approach for understanding the status of antitumor drug research and the future development of improved drugs. Provides a broad set of perspectives on the problem of antitumor drug development from tumor cell biology and drug screening to drug design and chemistry...read more
By William A. Remers (editor)

Hardcover:

9780471080800 | Krieger Pub Co, February 1, 1984, cover price $75.00 | About this edition: A multidisciplinary approach for understanding the status of antitumor drug research and the future development of improved drugs.

Hardcover:

9780865770959 | Thieme-Stratton Corp, April 1, 1984, cover price $75.00

cover image for 9780897662321
Product Description: 1983, hardcover edition, volume 419 in a series, New York Academy of Sciences, NY, 273 pages. Very technical. Figures / graphs / b&w photos. Presents a series of technical essays written by informed scholars in the field.
By Victor A. Najjar (editor)

Hardcover:

9780897662321 | New York Academy of Sciences, February 1, 1984, cover price $55.00 | About this edition: 1983, hardcover edition, volume 419 in a series, New York Academy of Sciences, NY, 273 pages.

cover image for 9781881025283
Discusses the use of antioxidants to reduce the risk of cancer, help prevent recurrences, and decrease the side effects of conventional treatments, and details which food supplements are essential for an antioxidant program.

Paperback:

9781881025283 | Equinox Pr, January 1, 2000, cover price $9.95 | About this edition: Discusses the use of antioxidants to reduce the risk of cancer, help prevent recurrences, and decrease the side effects of conventional treatments, and details which food supplements are essential for an antioxidant program.

cover image for 9780849355202
Product Description: Hardback book titled ANTITUMOR COMPOUNDS OF NATURAL ORIGIN.

Hardcover:

9780849355202 | CRC Pr I Llc, June 1, 1981, cover price $155.00 | About this edition: Hardback book titled ANTITUMOR COMPOUNDS OF NATURAL ORIGIN.

cover image for 9780849355219
Product Description: Book by Aszalos, Adorjan
By Adorjan Aszalos (editor)

Hardcover:

9780849355219 | CRC Pr I Llc, June 1, 1981, cover price $115.00 | About this edition: Book by Aszalos, Adorjan

cover image for 9780849346200
Product Description: This volume reviews the experimental data on drug-radiation interactions. Special emphasis is placed on clinically-useful antitumor drugs. Particular reference is made to appropriate timing, concentration and sequencing of drug-radiation combinations...read more

Hardcover:

9780849346200 | CRC Pr I Llc, January 1, 1990, cover price $289.95 | About this edition: This volume reviews the experimental data on drug-radiation interactions.

at beginning | displaying 1 to 25 | next 25 >